Cognitive enhancement research roundup, 2026

This page is a reference summary of published evidence and regulatory documents. It is not a substitute for individual medical advice, and it is not a recommendation to take or avoid any medicine.

Medically reviewed by Dr. Sofia Lindqvist, · Last reviewed 11 August 2026

The cognition literature moves slowly and is read quickly. Most headlines describe a single small crossover trial in rested young adults, which is the weakest design for the claim being made.

This roundup keeps the design attached to the finding.

Read the design before the result

Design	What it can show	What it cannot
Single-dose crossover, rested adults	Acute effect on a test battery	Durable real-world benefit
Sleep-deprived trial	Restoration of impaired performance	Enhancement above baseline
Clinical trial in a sleep disorder	Efficacy for the approved indication	Anything about healthy users
Meta-analysis	Pooled direction and size	Causes of heterogeneity between studies

The finding that keeps replicating

Wakefulness agents reliably restore performance that sleep loss has degraded. That result is robust across designs and decades.

Restoration of impaired performance and enhancement above a rested baseline are different claims with very different levels of support.

The finding that stays contested

Benefit in rested, healthy adults remains small, task-dependent and inconsistent. Executive function and attention tasks show the most signal. Creative and divergent tasks sometimes show a decrement. Effect sizes reported in 2026 reviews remain in the small range and vary with baseline performance.Verify against source

What to watch next

Longer-duration trials, outcome measures that resemble real work rather than lab tasks, and pre-registered protocols. Those three changes would do more for this field than another crossover study.

Frequently asked questions

Do these drugs make healthy people smarter?

The evidence does not support that framing. It supports a modest, uneven effect on some attention and executive tasks, largest where baseline performance is low.

Why do personal accounts sound stronger than the data?

Because they measure a felt state rather than performance, and because nobody publishes an uneventful week.